C.H. Robinson Worldwide heads into its Q2 earnings print on July 29 with a rare alignment: the stock is up 4.5% on the week, analysts are raising targets in unison, and yet shorts are quietly rebuilding their positions.
A burst of analyst activity over the past two days tells the most compelling story this week. The direction of travel is unmistakably bullish at the margin — Citizens initiated coverage this morning with a Market Outperform rating and a $235 target, Truist and Stifel both raised their buys to $215, and Susquehanna lifted to $226. Citigroup, maintaining a Neutral stance, edged its target up to $204, and Evercore held its Outperform with a $224 target. The outlier remains Morgan Stanley, which kept its Underweight on the stock with a target of just $91 — a figure that looks dramatically out of step with the current price of $199.61 and every other firm's assessment, and is worth treating with caution. Strip that aside and the Street consensus clusters in the $200–$235 range, with the mean sitting at $202, implying modest upside from here. The hold-heavy consensus — seven analysts at hold versus a handful of bullish names — suggests the Street acknowledges the recovery but isn't fully convinced on valuation. At 28.4x trailing earnings and an EV/EBITDA of 20.8x, CHRW carries a premium that the bear case flags as vulnerable if freight rates disappoint.
Short interest tells a more ambiguous story. Bears haven't gone away — SI climbed 3.7% over the past week to 6.4% of the free float, reversing a sharper 14% decline over the prior month. That monthly drawdown had suggested some short-side capitulation as the stock rallied; the weekly rebuild hints at skepticism ahead of the print. Borrow conditions remain loose, however. Availability is running at roughly 670% of outstanding short interest — meaning shares to borrow are abundant relative to those already lent — and the cost to borrow is just 0.53%, barely above its 30-day average despite an 11% weekly uptick. There is no squeeze pressure here; the borrow market is comfortably open, and new short positions are easy to establish. Options positioning corroborates the calm: the put/call ratio at 0.36 sits slightly above its 20-day average of 0.34 — just over one standard deviation — suggesting mild incremental defensiveness but nothing close to alarm.
The insider picture is mildly worth noting. The CEO sold 11,693 shares at $180.34 on June 26 — a $2.1 million disposal — and the CFO followed with a $897,000 sale on July 8 at $190.95. Both trades were marked with the lowest significance score, consistent with routine plan-driven activity rather than a directional statement. What is notable is that both the CEO and CFO were buyers in February at prices around $163–$168, locking in gains as the stock has moved sharply higher. Net insider activity over 90 days is a positive 17,595 shares, though that reflects the earlier buying; the recent trend is clearly toward selling into the rally.
The last two earnings releases offer a useful pattern. After the Q1 2026 report in early May, the stock added 1.7% the next session. After the prior quarter's report in late April, it fell 3.3% on day one and dropped 10.3% over the five days that followed. The one-day reaction was modest in both cases, but the five-day drift was the more meaningful signal — both positive and negative. Closest peer EXPD is up 7.5% on the week, outpacing CHRW's 4.5% gain. HUBG has also moved higher, up 2.6%. The freight tape is broadly constructive this week, which sets a reasonable backdrop heading into the Robinson print.
The key question on July 29 is whether the margin recovery that bulls are pricing at $215–$235 materialises in the Q2 numbers, or whether the freight rate environment has softened enough to give the short rebuilders a reason to add.
See the live data behind this article on ORTEX.
Open CHRW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
C.H. Robinson Worldwide heads into the back half of May with fresh analyst momentum, a stock that has clawed back from last month's post-earnings dip, and shorts that are quietly rebuilding — though not yet at levels…
C.H. Robinson Worldwide enters the end of April with a peculiar tension: a stock that has rallied 16% in a month while short sellers quietly rebuild positions — and Q1 results hitting after the close on April 29. Short…
